Owing to its high disability and mortality rates, stroke has been the second leading cause of
death worldwide. Since the pathological mechanisms of stroke are not fully understood …

It is well acknowledged that neuroprotective effects of transplanted mesenchymal stem cells
(MSCs) in ischemic stroke are attributed to their paracrine-mediated actions or bystander …

Aims: Hypoxic-ischaemic encephalopathy (HIE) is one of the most serious complications in
neonates and infants. Mesenchymal stromal cell (MSC)-based therapy is emerging as a …

Ischemic stroke occurs when the arteries supplying blood to the brain are narrowed or
blocked, inducing damage to brain tissue due to a lack of blood supply. One effective way to …

Stem cells offer new therapeutic avenues for the repair and replacement of damaged tissues
and organs owing to their self-renewal and multipotent differentiation capabilities. In this …

The precursor form of nerve growth factor (proNGF) is essential to maintain NGF survival
signaling. ProNGF is also among endogenous ligands for p75 neurotrophin receptor …

Traditional acupuncture and electroacupuncture (EA) have been widely performed to treat
ischemic stroke. To provide experimental support for the clinical application of acupuncture …

Stroke is the major cause of death and disability worldwide. Most stroke patients who survive
in the acute phase of ischemia display various extents of neurological deficits. In order to …

Mesenchymal stem cells (MSCs) represent the most clinically used stem cells in
regenerative medicine. However, due to the disadvantages with primary MSCs, such as …

Many neurons undergo apoptosis after ischemic stroke. In the brain, neurogenesis has the
potential for neuronal replacement and can be activated by external conditions to repair the …